Business Trends– category –
-
Physical AI Startup Atoms Leads $1.7 Billion Funding Round as AI Startup Investment Concentrates in Mega-Deals
Crunchbase News USA Overview Physical AI startup Atoms led a massive $1.7 billion funding round this week, exemplifying the trend of concentrated investment in mega-deals across AI, biotech, and cybersecurity. While total North American ... -
Chemical Recycling Plants in Europe and U.S. Face Closures and Project Halts Amid Commercial Viability Challenges
Chemistry World Europe, USA Overview Chemical recycling plants in Europe and the United States are struggling to achieve commercial viability, leading to a wave of closures and project halts. The administration of Plastic Energy in the U... -
Evonik Completes Backward Integration of Global MetAMINO® Production Network, Boosting Supply Security and Efficiency
Evonik Industries Germany, Global Overview Evonik announced the completion of backward integration for its global MetAMINO® (DL-methionine) production network. This achievement enables the company to produce the key intermediate, methyl ... -
BASF Inaugurates New Multi-Million Euro Production Plant in Düsseldorf, Germany, for Specialty Emollients in Skincare
BASF Germany Overview BASF officially opened a new state-of-the-art production plant in Düsseldorf, Germany, on July 16, 2026, dedicated to manufacturing specialty emollients for skincare and sun protection products. This multi-million e... -
IBM to Acquire HRL Laboratories, Significantly Expanding Quantum Computing Capabilities
GovCon Wire USA Overview IBM has agreed to acquire HRL Laboratories, a research facility co-owned by Boeing and General Motors, marking a significant strategic move to expand its quantum computing capabilities. This acquisition will inte... -
American Binary Unveils NSA CNSA 2.0 Compliant Quantum-Resistant Cryptography Architecture ‘Ambit Client’
Cyber Defense Magazine USA Overview American Binary has announced its 'Ambit Client,' a quantum-resistant cryptographic architecture designed to meet the NSA's CNSA 2.0 requirements for National Security Systems. The product offers full ... -
Sonoma Biotherapeutics Automates Autologous CAR-Treg Therapy Manufacturing for Rheumatoid Arthritis with Cellares’ Cell Shuttle Platform
Regen Report USA Overview Sonoma Biotherapeutics partnered with Cellares to automate manufacturing of its Phase 1 autologous CAR-Treg therapy (SBT-77-7101) for treatment-resistant rheumatoid arthritis, using Cellares' Cell Shuttle platfo... -
FDA Clears Prime Medicine’s In Vivo Prime Editor for Wilson Disease, Setting Stage for 2027 Data
BioSpace USA Overview Prime Medicine has secured FDA Investigational New Drug (IND) clearance for PM577a, an in vivo Prime Editor designed to correct the H1069Q mutation in Wilson disease. This approval initiates a global Phase 1/2 clini... -
Eli Lilly Acquires Kelonia and Orna Therapeutics as Investment in In Vivo Cell Therapies Surges, Aiming to Reduce Treatment Burden and Manufacturing Costs
DCAT Value Chain Insights USA Overview In vivo cell therapies, where the patient's body becomes the manufacturing site for cells like CAR T cells, are attracting substantial biopharmaceutical investment due to their potential to reduce t... -
FDA Approves Orca Bio’s Precision-Engineered Cell Therapy Tregzi (Orca-T) for Allogeneic Transplant in Adults with Hematological Malignancies
CliniExpert USA Overview The U.S. FDA has approved Orca Bio’s precision-engineered cell therapy, Tregzi™ (Orca-T®), for allogeneic transplant in adult patients with hematological malignancies. Tregzi is a personalized therapy manufacture...
